Parkinson's Disease Therapeutics Pipeline Program
The Michael J. Fox Foundation for Parkinson's Research
Free. Verify your email, then we send one reminder only.
- Posted
- Jun 10, 2026
- Closes
- Rolling, no fixed deadline
Similar opportunities open now
- Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN) Powering the Next Generation of ResearchOpenThe Michael J. Fox Foundation for Parkinson's ResearchNo deadline listedUp to $250K
- CFF: Path to a Cure Pioneer AwardOpenCystic Fibrosis FoundationCloses Dec 2026
- Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)OpenNational Institutes of HealthCloses Dec 2027
- CFF: Clinical Pilot and Feasibility AwardOpenCystic Fibrosis FoundationCloses in 11 daysUp to $150K
- Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)OpenNational Institutes of HealthCloses Nov 2027Up to $1.5M
Amount
Amount not published by the funder
Who can apply
Who Can Apply Open to industry, academic/industry partnerships, and—in certain cases—academic-led projects; access the downloadable RFA overview below for full eligibility details…
About this opportunity
Our flagship funding initiative accelerates Parkinson’s disease therapy development by prioritizing opportunities where our funding supports generation of meaningful evidence informing critical development milestones. Our flagship funding initiative accelerates Parkinson’s disease therapy development by prioritizing opportunities where our funding supports generation of meaningful evidence informing critical development milestones. As the primary focus of TPP is to advance new therapeutic interventions, MJFF will NOT consider proposal submissions to this program that focus on the following areas: The program will be divided into two stages with the goal of offering applicants frequent opportunities to propose novel and promising PD therapeutics:
Related opportunities
- Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN) Powering the Next Generation of ResearchThe Michael J. Fox Foundation for Parkinson's ResearchUp to $250K
- CFF: Path to a Cure Pioneer AwardCystic Fibrosis FoundationCloses Dec 2026
- Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)National Institutes of HealthCloses Dec 2027
- CFF: Clinical Pilot and Feasibility AwardCystic Fibrosis FoundationCloses in 11 daysUp to $150K
- Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)National Institutes of HealthCloses Nov 2027Up to $1.5M